Wet Wrap Therapy in Children with Moderate to Severe Atopic Dermatitis in a Multidisciplinary Treatment Program

被引:51
作者
Nicol, Noreen Heer [1 ,2 ]
Boguniewicz, Mark [3 ]
Strand, Matthew [4 ]
Klinnert, Mary D. [3 ]
机构
[1] Univ Colorado, Coll Nursing, Aurora, CO 80045 USA
[2] Childrens Hosp Colorado, Dept Nursing, Aurora, CO USA
[3] Natl Jewish Hlth, Dept Pediat, Denver, CO USA
[4] Natl Jewish Hlth, Dept Biostat, Denver, CO USA
关键词
Wet wrap therapy; Atopic dermatitis; Management; Outcomes; INTERVENTION TREATMENT; EPIDERMAL BARRIER; EFFICACY; ECZEMA; DRESSINGS; CORTICOSTEROIDS; PREVALENCE; SAFETY;
D O I
10.1016/j.jaip.2014.04.009
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
BACKGROUND: Atopic dermatitis (AD) is the most common chronic, relapsing inflammatory skin disease of children and is a global public health problem. National and international AD guidelines address AD care in a stepwise fashion. Wet wrap therapy (WWT) is a therapeutic intervention for moderate-to-severe AD. OBJECTIVE: This cohort study evaluated the effectiveness of WWT as part of a multidisciplinary AD treatment program to improve disease severity. Patients treated in this unique outpatient program had moderate-to-severe AD and had multiple therapies that failed. METHODS: An observational cohort study was completed. The primary outcome was improvement in AD severity as measured by SCORAD (Scoring Atopic Dermatitis). Demographics; clinical management of AD, including use of antibiotics and systemic treatments; and WWT methodology were comprehensively described. RESULTS: Seventy-two children with a mean +/- SD age of 4.6 +/- 3.12 years were included. By using a paired t test, the SCORAD at admission and at discharge showed significant differences in mean -SD values, of 49.68 +/- 17.72 versus 14.83 +/- 7.45, respectively (t, 18.93; df, 71; P < .001). None of these patients required systemic immunosuppressive therapy during the treatment program. By using a previously published parent-administered outcomes tool, patients were shown to maintain clinical improvement of their AD 1 month after discharge. CONCLUSION: To our knowledge, this study is the largest to date of WWT for pediatric patients with moderate-to-severe AD by using a validated outcomes tool. None of the patients required systemic immunosuppressive therapy, and only 31% were treated with an oral antibiotic. This study demonstrated the benefit of incorporating WWT as an acute intervention in a supervised multidisciplinary AD treatment program with lasting benefit 1 month after discontinuing this intervention. (C) 2014 American Academy of Allergy, Asthma & Immunology
引用
收藏
页码:400 / 406
页数:7
相关论文
共 29 条
[1]  
Abeck D, 1999, HAUTARZT, V50, P418, DOI 10.1007/s001050050934
[2]   Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report [J].
Akdis, Cezmi A. ;
Akdis, Mubeccel ;
Bieber, Thomas ;
Bindslev-Jensen, Carsten ;
Boguniewicz, Mark ;
Eigenmann, Philippe ;
Hamid, Qutayba ;
Kapp, Alexander ;
Leung, Donald Y. M. ;
Lipozencic, Jasna K. ;
Luger, Thomas A. ;
Muraro, Antonella ;
Novak, Natalija ;
Platts-Mills, Thomas A. E. ;
Rosenwasser, Lanny ;
Scheynius, Annika ;
Simons, F. Estelle R. ;
Spergel, Jonathan ;
Turjanmaa, Kristiina ;
Wahn, Ulrich ;
Weidinger, Stefan ;
Werfel, Thomas ;
Zuberbier, Torsten .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (01) :152-169
[3]   A pilot study on the use of wet wraps in infants with moderate atopic eczema [J].
Beattie, PE ;
Lewis-Jones, MS .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2004, 29 (04) :348-353
[4]   Conventional therapy for atopic dermatitis [J].
Boguniewicz, M ;
Nicol, N .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2002, 22 (01) :107-+
[5]   A multidisciplinary approach to evaluation and treatment of atopic dermatitis [J].
Boguniewicz, Mark ;
Nicol, Noreen ;
Kelsay, Kim ;
Leung, Donald Y. M. .
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2008, 27 (02) :115-127
[6]   Atopic dermatitis: a disease of altered skin barrier and immune dysregulation [J].
Boguniewicz, Mark ;
Leung, Donald Y. M. .
IMMUNOLOGICAL REVIEWS, 2011, 242 :233-246
[7]   The Atopic Dermatitis Quickscore (ADQ): validation of a new parent-administered atopic dermatitis scoring tool [J].
Carel, Kirstin ;
Bratton, Donna L. ;
Miyazawa, Naomi ;
Gyorkos, Elizabeth ;
Kelsay, Kimberly ;
Bender, Bruce ;
Strand, Matthew ;
Atkins, Dan ;
Gelfand, Erwin W. ;
Klinnert, Mary D. .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 101 (05) :500-507
[8]   The psychosocial burden of childhood atopic dermatitis [J].
Chamlin, SL .
DERMATOLOGIC THERAPY, 2006, 19 (02) :104-107
[9]   Outcome measures of disease severity in atopic eczema [J].
Charman, C ;
Williams, H .
ARCHIVES OF DERMATOLOGY, 2000, 136 (06) :763-769
[10]   New perspectives on epidermal barrier dysfunction in atopic dermatitis: Gene-environment interactions [J].
Cork, Michael J. ;
Robinson, Darren A. ;
Vasilopoulos, Yiannis ;
Ferguson, Adam ;
Moustafa, Manar ;
MacGowan, Alice ;
Duff, Gordon W. ;
Ward, Simon J. ;
Tazi-Ahnini, Rachid .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (01) :3-21